Phibro Animal Health reported $268.37M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Align Technology ALGN:US USD 3.6B 93.26M
Ani Pharmaceuticals ANIP:US USD 338.54M 1.86M
Aurora Cannabis Inc ACB:CN CAD 558.82M 2.36M
Canopy Growth Corp WEED:CN CAD 1.49B 191.63M
Corcept Therapeutics CORT:US USD 501.84M 28.48M
Depomed DEPO:US USD 225.72M 90.81M
Endo International Ordinary Shares ENDP:US USD -3925041000 726.97M
Henry Schein HSIC:US USD 3.45B 165M
Idexx Laboratories IDXX:US USD 608.74M 132.74M
Knight Therapeutics Inc GUD:CN CAD 825.86M 28.66M
Lannett LCI:US USD -312274000 34.71M
Nektar Therapeutics NKTR:US USD 366.64M 45.58M
Pacira Pharmaceuticals PCRX:US USD 775.01M 4.89M
Patterson Companies PDCO:US USD 1.1B 60.4M
Phibro Animal Health PAHC:US USD 268.37M 5.61M
Prestige Brands PBH:US USD 1.69B 67.02M
Supernus Pharmaceuticals SUPN:US USD 886.2M 33.41M
Teva Pharmaceutical Industries TEVA:US USD 7.9B 871M
Zoetis ZTS:US USD 4.4B 258M